NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
29 hedge funds and large institutions have $991K invested in NeuBase Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$42.7K | |
| 2 | +$12K | |
| 3 | +$11.5K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.8K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$2K |
Top Sellers
| 1 | -$33K | |
| 2 | -$11K | |
| 3 | -$8.47K | |
| 4 |
GBA
Garrison Bradford & Associates
New York
|
-$7.8K |
| 5 |
FNBT
FineMark National Bank & Trust
Fort Myers,
Florida
|
-$4K |